Selective EZH2 inhibitor zld1039 alleviates inflammation in cisplatin-induced acute kidney injury partially by enhancing RKIP and suppressing NF-κB p65 pathway

Wen Li(West China Hospital of Sichuan University), Shaohua Tao(Sichuan University), Fan Guo(West China Hospital of Sichuan University), Ling-Zhi Li(Sichuan University), Hongliu Yang(West China Hospital of Sichuan University), Yan Liang(West China Hospital of Sichuan University), Lidan Zhang(West China Hospital of Sichuan University), Liang Ma(West China Hospital of Sichuan University), Ping Fu(West China Hospital of Sichuan University)
Acta Pharmacologica Sinica
December 22, 2021
10.1038/s41401-021-00837-8
Cited by 34Open Access
Full Text

Abstract

Related Papers

PhosphoSitePlus, 2014: mutations, PTMs and recalibrations
Peter Hornbeck, Bin Zhang, Beth Murray et al.|Nucleic Acids Research|2014|3.4k
Integrating cell-signalling pathways with NF-κB and IKK function
Neil D. Perkins|Nature Reviews Molecular Cell Biology|2006|2.3k
Genome Regulation by Polycomb and Trithorax Proteins
Bernd Schuettengruber, Daniel Chourrout, Michel Vervoort et al.|Cell|2007|1.4k
Acute kidney injury: an increasing global concern
Norbert Lameire, Arvind Bagga, Dinna N. Cruz et al.|The Lancet|2013|998
Interplay between the Cancer Genome and Epigenome
Hui Shen, Peter W. Laird|Cell|2013|922